Added To 600,000 Tests, YHLO And C-Mer Donated COVID-19 Antigen Tests To Hong Kong Again
Shenzhen YHLO and its Hong Kong partner, Hong Kong C-Mer (C-Mer Eye Care Holdings Limited), announced that they donated once again to the Hong Kong society on February 22, after the donation of 300,000 YHLO COVID-19 Rapid Antigen Tests to the Hong Kong on February 16. The total number of the donations increased to 600,000 tests. YHLO and C-Mer are joining hands to help Hong Kong citizens to fight against COVID-19.
Attachments:
MORE NEWS
n November 18, 2025, YHLO’s 2025 Global Core Distributors Conference was successfully held in Düsseldorf, Germany. Under the theme “Academia-Driven, Shared Value,” the meeting brought together representatives from more than 30 core distributors worldwide. YHLO’s founder, Mr. Deming Hu, and Chairman, Mr. Kunhui Hu, led the company’s executive team to attend and discuss strategic development with partners.
2025-11-20
YHLO Secures Approval for the World’s First sCD146 CLIA Assay
YHLO has obtained approval from the Guangdong Medical Products Administration for its soluble CD146 (sCD146) CLIA assay, marking a major milestone in central nervous system (CNS) disease diagnostics. YHLO is now the first company worldwide to offer an sCD146 test for cerebrospinal fluid, bringing its total CLIA assay portfolio in China to 173.
2025-11-18
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
